4-(2-(Pyrrolidin-1-yl)ethoxy)aniline → N(8)-(2-Methanesulfonyl-benzyl)-N(2)-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-[1,2,4]triazolo[1,5-a]pyridine-2,8-diamine

HRID 472415Notes

Reaction equation

HRID 472415 reaction equation
Cl[C:2]1[N:22]=[C:5]2[C:6]([NH:10][CH2:11][C:12]3[CH:17]=[CH:16][CH:15]=[CH:14][C:13]=3[S:18]([CH3:21])(=[O:20])=[O:19])=[CH:7][CH:8]=[CH:9][N:4]2[N:3]=1.[N:23]1([CH2:28][CH2:29][O:30][C:31]2[CH:36]=[CH:35][C:34]([NH2:37])=[CH:33][CH:32]=2)[CH2:27][CH2:26][CH2:25][CH2:24]1.C1(P(C2CCCCC2)C2C=CC=CC=2C2C=CC=CC=2P(C2CCCCC2)C2CCCCC2)CCCCC1>>[CH3:21][S:18]([C:13]1[CH:14]=[CH:15][CH:16]=[CH:17][C:12]=1[CH2:11][NH:10][C:6]1[C:5]2[N:4]([N:3]=[C:2]([NH:37][C:34]3[CH:35]=[CH:36][C:31]([O:30][CH2:29][CH2:28][N:23]4[CH2:27][CH2:26][CH2:25][CH2:24]4)=[CH:32][CH:33]=3)[N:22]=2)[CH:9]=[CH:8][CH:7]=1)(=[O:20])=[O:19]

Participants

4

Procedure

N(8)-(2-Methanesulfonyl-benzyl)-N(2)-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-[1,2,4]triazolo[1,5-a]pyridine-2,8-diamine was prepared from (2-chloro-[1,2,4]triazolo[1,5-a]pyridin-8-yl)-(2-methanesulfonyl-benzyl)-amine (75.0 mg, 0.223 mmol) and 4-(2-pyrrolidin-1-yl-ethoxy)-phenylamine (51.0 mg, 0.247 mmol) with 2,2′-bis-dicyclohexylphosphanyl-biphenyl (25.0 mg, 0.0457 mmol) as the ligand in a manner analogous to Example 2d. Product isolated as a tan foam (0.037 g, 33%). 1H NMR (400 MHz, CDCl3, δ, ppm): 8.11 (d, J=7.8 Hz, 1H), 7.84 (d, J=6.6 Hz, 1H), 7.67-7.58 (m, 2H), 7.52 (t, J=6.9 Hz, 1H), 7.46 (d, J=8.8 Hz, 2H), 6.92 (d, J=8.8 Hz, 2H), 6.68 (t, J=7.5 Hz, 1H), 6.52 (s, 1H), 6.42 (d, J=7.6 Hz, 1H), 5.28 (t, J=6.0 Hz, 1H), 4.96 (d, J=6.2 Hz, 2H), 4.12 (t, J=5.6 Hz, 2H), 3.16 (s, 3H), 2.96-2.88 (m, 2H), 2.67 (br s, 4H), 1.89-1.76 (m, 4H). MS=507 (MH)+.

Sources & evidence

ORD record
ord-24d2f058d4474c74a84abc563dd61b68
Source dataset
uspto-grants-2014_01
Patent number
US08633173B2

Reaction notes

Loading…